Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066425
Filing Date
2025-05-08
Accepted
2025-05-08 08:07:59
Documents
79
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rkda-20250331.htm   iXBRL 10-Q 2118663
2 EX-10.1 rkda-ex10_1.htm EX-10.1 58613
3 EX-31.1 rkda-ex31_1.htm EX-31.1 14561
4 EX-31.2 rkda-ex31_2.htm EX-31.2 14630
5 EX-32.1 rkda-ex32_1.htm EX-32.1 9332
6 EX-32.2 rkda-ex32_2.htm EX-32.2 9289
  Complete submission text file 0000950170-25-066425.txt   10807683

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20250331.xsd EX-101.SCH 1852046
82 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20250331_htm.xml XML 2064426
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37383 | Film No.: 25923995
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)